Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

WASP and the phenotypic range associated with deficiency.

Luigi D Notarangelo1, Lucia D Notarangelo, Hans D Ochs

  • 1Department of Pediatrics and Angelo Nocivelli Institute for Molecular Medicine, University of Brescia, Spedali Civili, Brescia, Italy. notarang@med.unibs.it

Current Opinion in Allergy and Clinical Immunology
|November 3, 2005
PubMed
Summary

Wiskott-Aldrich Syndrome Protein (WASP) gene mutations cause varied clinical phenotypes. WASP protein expression predicts disease severity, and gene therapy shows promise for treating WAS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Nature immunology·2026
Same author

Revisiting X-linked agammaglobulinemia.

Journal of human immunity·2026
Same author

FDA approves gene therapy for Wiskott-Aldrich syndrome.

The Journal of allergy and clinical immunology·2026
Same author

Treatment of canine hemophilia A via intraosseous delivery of a platelet-specific factor VIII-lentiviral vector.

Blood vessels, thrombosis & hemostasis·2026
Same author

Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.

Clinical immunology (Orlando, Fla.)·2025
Same author

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.

Blood advances·2025

Area of Science:

  • Immunology
  • Genetics
  • Hematology

Background:

  • Wiskott-Aldrich Syndrome (WAS) is an X-linked immunodeficiency disorder.
  • Mutations in the Wiskott-Aldrich Syndrome Protein (WASP) gene underlie WAS.
  • Understanding genotype-phenotype correlations is crucial for patient management.

Purpose of the Study:

  • To review clinical phenotypes associated with WASP gene mutations.
  • To discuss genotype-phenotype correlations in WAS.
  • To present advances in preclinical gene therapy models for WAS.

Main Methods:

  • Review of recent studies on WAS and X-linked thrombocytopenia.
  • Analysis of WASP protein expression as a predictor of phenotype.
  • Evaluation of autoimmune manifestations in WAS patients.

Related Experiment Videos

  • Assessment of hematopoietic stem cell transplantation and gene transfer approaches.

    • Main Results:

    • Genotype-phenotype correlation is supported by recent studies.
    • WASP protein expression level is the strongest predictor of clinical phenotype.
    • Autoimmune hemolytic anemia and elevated serum IgM correlate with severe WAS.
    • Gene therapy using lentiviral vectors shows potential for improved immune function reconstitution.

    Conclusions:

    • WASP expression analysis confirms genotype-phenotype correlation in WAS patients.
    • WASP protein expression serves as a critical prognostic indicator.
    • Advances in gene transfer offer new therapeutic possibilities for WAS.